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1	Introduction
Leber	hereditary	optic	neuropathy	(LHON)	is	a	kind	of	blindness	mostly	due	to	mitochondrial	DNA	(mtDNA)	mutations	in	genes	coding	for	respiratory	complex	I	(CI)	polypeptides.	Some	individuals,	despite	harboring	an	mtDNA
pathologic	mutation,	fail	to	express	the	phenotype	(Maresca	et	al.,	2014).	Sometimes,	incomplete	penetrance	can	be	explained	by	differences	in	the	mutation	load	(Jacobi	et	al.,	2001).	However,	LHON	patients	are	usually	homoplasmic,
i.e.	100%	of	their	mtDNA	molecules	are	mutated.	Then,	other	factors	must	be	considered	to	justify	phenotypic	differences.	Thus,	it	has	been	shown	that	mtDNA	genetic	backgrounds,	such	as	mtDNA	haplogroups	J	or	K,	can	alter	the
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Abstract
Mitochondrial	DNA	mutations	in	genes	encoding	respiratory	complex	I	polypeptides	can	cause	Leber	hereditary	optic	neuropathy.	Toxics	affecting	oxidative	phosphorylation	system	can	also	cause	mitochondrial	optic
neuropathy.	Some	complex	I	inhibitors	found	in	edible	plants	might	differentially	interact	with	these	pathologic	mutations	and	modify	their	penetrance.	To	analyze	this	interaction,	we	have	compared	the	effect	of	rotenone,
capsaicin	 and	 rolliniastatin-1	 on	 cybrids	 harboring	 the	most	 frequent	 Leber	 hereditary	 optic	 neuropathy	mutations	 and	 found	 that	m.3460G > A	mutation	 increases	 rotenone	 resistance	 but	 capsaicin	 and	 rolliniastatin-1
susceptibility.	Thus,	to	explain	the	pathogenicity	of	mitochondrial	diseases	due	to	mitochondrial	DNA	mutations,	their	potential	interactions	with	environment	factors	will	have	to	be	considered.
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LHON	susceptibility	(Hudson	et	al.,	2007).	Maternal	relatives	share	the	mtDNA	genotype	but	more	males	than	females	develop	LHON	(Franks	and	Sanders,	1990).	The	difference	in	sex	susceptibility	can	be	attributed	to	the	effect	of
estrogens	that	ameliorate	LHON	mitochondrial	dysfunction	(Giordano	et	al.,	2011).	LHON	peak	age	of	onset	is	between	15	and	30	years	(Dimitriadis	et	al.,	2014).	Maybe,	healthy	individuals	differ	from	maternally	related	patients
because	they	have	not	reached	a	particular	age.	However,	reports	of	healthy	individuals,	older	than	patients,	are	not	rare	in	LHON	homoplasmic	mutant	pedigrees	(Vilkki	et	al.,	1989).
Previous	observations	suggested	 that	other	 factors	 should	be	 invoked	 to	explain	phenotypic	differences	between	LHON	homoplasmic	mutant	healthy	 individuals	and	patients	with	similar	ages	and	 the	same	mitochondrial
genetic	background	and	gender.	It	was	found	that	mutant	(m.3460G > A)	osteosarcoma	143B	cybrids	showed	severe	CI	deficiency.	However,	a	biochemical	defect	was	not	apparent	in	adenocarcinoma	A549	cybrids	harboring	the	same
mutation	(Cock	et	al.,	1998).	These	results	suggested	that	the	nuclear	genetic	(nDNA)	background	influences	the	expression	of	the	biochemical	defect	in	LHON	patients.	In	fact,	it	has	been	recently	found	that	a	genetic	variant	of	the
nDNA-encoded	mitochondrial	enzyme	tyrosyl-tRNA	synthetase,	which	decreases	OXPHOS	capacity,	is	a	nuclear	modifier	for	LHON	(Jiang	et	al.,	2016a).
The	 exposure	 to	 environmental	 factors	might	 also	 explain	phenotypic	 differences	 among	homoplasmic	 individuals	 from	 the	 same	maternal	 pedigree,	 same	gender	 and	 similar	 age.	For	 example,	 two	brothers	 carrying	 the
m.11778G > A	homoplasmic	mutation	showed	a	different	phenotype.	The	index	case	developed	LHON	at	the	age	of	60	years	after	a	long	history	of	occupational	exposure	to	polycyclic	aromatic	hydrocarbons	(PAHs).	However,	his	59
years	old	brother	was	unaffected	(Rufa	et	al.,	2005).	A	34	years	old	individual	harboring	the	m.11778G > A	homoplasmic	mutation	developed	LHON	after	his	exposure	to	erythromycin	but	three	homoplasmic	mutant	brothers	(33,	31
and	13	years	old)	did	not	have	vision	problems	(Luca	et	al.,	2004).	As	LHON	mutations	mainly	affect	CI	polypeptides,	the	exposure	to	CI	inhibitors	may	imitate	the	phenotype.	In	fact,	after	the	infusion	of	rotenone	microspheres	into	the
rat's	optical	layer	of	the	superior	colliculus,	animals	exhibited	several	signs	comparable	to	those	observed	in	human	LHON	patients	(Zhang	et	al.,	2015).	The	number	of	known	CI	inhibitors	is	increasing	and	the	exposure	to	natural
origin	CI	inhibitors	is	difficult	to	avoid	(Degli	Esposti,	1998).	These	compounds	may	differentially	modify	the	phenotype	due	to	LHON	mutations.	Therefore,	we	decided	to	check	the	interaction	between	CI	inhibitors	found	in	edible
plants,	such	as	capsaicin	and	rolliniastatin-1	(Fig.	1),	and	the	most	frequent	LHON	mutations.	As	a	control,	we	used	rotenone,	a	frequently	used	CI	inhibitor.
2	Material	and	methods
To	homogenize	nuclear	and	environmental	 factors,	we	built	cybrids	with	 the	osteosarcoma	143B	rho0	nuclear	background	using	patient	and	control	platelets	(Chomyn	et	al.,	1994).	All	 samples	were	collected	with	written
informed	consent	and	the	Ethics	Review	Committees	of	the	involved	hospitals	and	the	Government	of	Aragón	approved	the	study	(Comité	Ético	de	Investigación	Clínica	de	Aragón-CEICA-12/2014).	These	cybrids	were	maintained	in
Dulbecco's	modified	eagle	medium	with	no	antibiotics	and	containing	glucose	(4.5 g/l),	pyruvate	(0.11 g/l)	and	fetal	bovine	serum	(5%).	To	perform	the	experiments,	glucose	concentration	was	reduced	to	1.0 g/l.
Screening	for	the	three	primary	LHON	mutations	was	done	by	polymerase	chain	reaction/restriction	fragment	length	polymorphism	(Emperador	et	al.,	2018).	The	complete	mtDNA	was	amplified	and	sequenced	according	to
previously	described	protocols	(Emperador	et	al.,	2018).	The	conservation	index	was	used	to	predict	detrimental	effects	of	mtDNA	missense	mutations	(Martin-Navarro	et	al.,	2017).	The	AmpFLSTR®	Identifiler®	PCR	Amplification	Kit
(Life	Technologies)	was	used	to	determine	the	cybrids	nDNA	genetic	fingerprints.	The	molecular	cytogenetic	analysis	was	done	according	to	already	published	procedures	(Lopez-Gallardo	et	al.,	2016).
Oxygen	consumption	and	caspase-3	activation	analyses	were	performed	according	to	previously	described	protocols	(De	Miguel	et	al.,	2013;	Gomez-Duran	et	al.,	2010).	CI	inhibitors	were	added	during	the	oxygen	consumption,
or	two	days	before	the	caspase-3,	studies.
Fig.	1	Respiratory	complex	I	(CI)	inhibitors.	The	structural	formula	of	CI	substrate	(A)	and	inhibitors	(B-D)	are	represented.
alt-text:	Fig.	1
The	three-dimensional	structure	of	the	bovine	p.	MT-ND1	subunit	(PDB	5LNK),	ortholog	of	human	p.	MT-ND1,	was	obtained	with	the	RasMol	2.6	program	(http://www.rasmol.org).
3	Results
3.1	Characterization	of	cybrid	cell	lines
Transmitochondrial	cell	lines	(cytoplasmic	hybrids	or	cybrids)	allow	an	important	homogenization	of	physiologic	factors	and	nuclear	genetic	backgrounds	(Iglesias	et	al.,	2012).	Therefore,	phenotypic	differences	between	LHON
and	wild-type	cybrids	should	be	mostly	due	to	their	mtDNA	genotypes.
To	analyze	the	effects	of	different	LHON	mutations	on	mitochondrial	bioenergetics,	we	first	built	4	osteosarcoma	143B	cybrid	cell	lines	harboring	wild-type	mtDNA	(Owt)	or	LHON	(m.3460G > A,	O3460;	m.11778G > A,	O11778;
m.14484T > C,	O14484)	mutations	and	3	adenocarcinoma	A549	cybrid	cell	lines	with	(m.3460G > A,	A3460;	m.11778G > A,	A11778)	or	without	(Awt)	LHON	mutations	(Fig.	2A).	To	confirm	that	they	shared	the	nuclear	background,	we
performed	a	nuclear	genetic	fingerprint	of	16	short	tandem	repeats	(STRs).	Osteosarcoma	143B	cybrids	showed	the	same	nuclear	markers	and	coincided	with	those	reported	in	American	Type	Culture	Collection	(ATCC)	osteosarcoma
143B	parental	cells	(Table	1A).	There	were	some	minor	differences	between	adenocarcinoma	A549	cybrids	and	only	one	difference	with	those	reported	in	ATCC	adenocarcinoma	A549	parental	cells	(Table	1A).	Karyotyping	was	used	to
verify	that	nuclear	backgrounds	were	equivalent	(Fig.	2B).	To	rule	out	the	presence	of	other	mtDNA	mutations	that	could	affect	cybrid	bioenergetics	phenotypes,	we	sequenced	the	whole	mtDNAs.	Non-synonymous	mutations	changed
evolutionary	poorly	conserved	amino	acids	and,	probably,	with	no	functional	importance	(Table	1B).
Table	1	Cybrid	genetic	characterization.
alt-text:	Table	1
A.	Nuclear	genetic	fingerprint.
Chr Marker O143B
(ATCC)
Owt O3460 O11778 O14484 A549
(ATCC)
Awt A3460 A11778
2 D2S1338 24,25 24,25 24,25 24,25 24,25 24,25 24,25
2 TPOX 11 11 11 11 11 8,11 8,11 8,11 8,11
3 D3S1358 15 15 15 15 16 16 16,17
Fig.	2	Characterization	of	cybrid	cell	lines.	A)	Confirmation	of	LHON	mtDNA	mutations.	Gels	showing	the	results	of	restriction	fragment	length	polymorphism	analyses.	B)	Karyotypes.	Representative	images	of	metaphase	preparations.	Chromosome	modal	number	and	range	(in
brackets)	are	indicated.	C)	Basal	oxygen	consumption.	The	value	for	each	wild-type	(Owt	or	Awt)	cybrid	is	considered	100%	(dashed	line).	D)	Active	caspase-3	levels.	The	value	for	each	wild-type	(Owt	or	Awt)	cybrid	is	considered	100%	(dashed	line).	*	(vs	Owt	or	Awt),	P	≤	0.0284.
alt-text:	Fig.	2
3 D3S1358 15 15 15 15 16 16 16,17
4 FGA 24 24 24 24 23 23 23
5 D5S818 13 13 13 13 13 11 11,12 11,12 11
5 CSF1PO 12 12 12 12 12 10,12 10,12 10,12 10,12
7 D7S820 11,12 11,12 11,12 11,12 11,12 8,11 8,11 8,11 8,11
8 D8S1179 11,14 11,14 11,14 11,14 13,14 13,14 13,14
11 TH01 6 6 6 6 6 8,9.3 8,9.3 8,9.3 8,9.3
12 vWA 18 18 18 18 18 14 14 14 14
13 D13S317 12 12 12 12 12 11 11 11 11
16 D16S539 10,13 10,13 10,13 10,13 10,13 11,12 11,12 11,12 11,12
18 D18S51 17 17 17 17 14,17 14,17 14,17
19 D19S433 13 13 13 13 13 13 13
21 D21S11 31.2,32.2 31.2,32.2 31.2,32.2 31.2,32.2 29 29 29,30
X AMEL X X X X X X,Y X,Y X,Y X,Y
Chr,	chromosome.	ATCC,	American	type	culture	collection.	Italic	numbers	indicate	differences	between	A549	cybrids.
B.	mtDNA	sequence
Cybrid Owt O3460 O11778 O14484 Awt A3460 A11778
GenBank JN635299 MH080305 MH080306 MH080307 KT002149 MH080308 MH080309
Haplogroup J1c8a J1c2e2 J1c1b J2a2c U5a1a2b T2b T2a1b1a1b
Pathologic 3460 11778 14484 3460 11778
Mutation (MT-ND1) (MT-ND4) (MT-ND6) (MT-ND1) (MT-ND4)
Private
Mutations
185
(MT-DLOOP)
3387A
(MT-ND1)
14189
(MT-ND6)
16241
(MT-DLOOP)
10398
(MT-ND3)
12131
(MT-ND4)
14198
(MT-ND6)
188
(MT-DLOOP)
482
(MT-DLOOP)
501
(MT-DLOOP)
5231
(MT-ND2)
6275
(MT-CO1)
7269
(MT-CO1)
11377
(MT-ND4)
14569
(MT-ND6)
15148
(MT-CYB)
15530
(MT-CYB)
12040
(MT-ND4)
1547Ti
(MT-RNR1)
12121
(MT-ND4)
16051
(MT-DLOOP)
16086
(MT-DLOOP)
16218
(MT-DLOOP)
Non-synonymous	private	mutations	are	indicated	in	bold	font.	mtDNA	position,	affected	polypeptide,	amino	acid	substitution	and	conservation	index	(CI)	of	wild-type	amino	acid	are	shown	next:	3387A	(p.MT-
ND1:I27M,	CI = 23.5%);	7269	(p.MT-CO1:V456M,	CI = 8.4%);	10398	(p.MT-ND3:A114T,	backmutation);	12131	(p.MT-ND4:S458P,	CI = 1.2%);	14189	(p.MT-ND6:V162A,	CI = 13.9%);	14198	(p.MT-ND6:T159M,
CI = 2.6%).	Haplogroup	assignation	according	to	(van	Oven	and	Kayser,	2009).
C.	Amino	acid	variation	at	p.MT.ND1,3	subunits
Cybrid p.MT-ND1 p.MT-ND3
Owt 15I,27M,30Y,52A,304H 9T,114T
O3460 15I,27I,30Y,52T,304H 9I,114T
O11778 15I,27I,30H,52A,304H 9I,114A
O14484 15I,27I,30Y,52A,304H 9I,114A
Awt 15I,27I,30Y,52A,304Y 9I,114T
A3460 15I,27I,30Y,52T,304H 9I,114T
A11778 15T,27I,30Y,52A,304H 9I,114T
Cybrid	differences	in	p.MT-ND1,3	amino	acids	are	shown	in	bold	font.
To	 check	 the	phenotypic	 effect	 of	 these	LHON	mutations	 in	 cybrids,	we	 analyzed	 endogenous	 oxygen	 consumption,	which	provides	 clues	 on	 cell	 respiration	 (Hofhaus	et	 al.,	 1996),	 and	 active	 caspase-3	 levels,	 a	marker	 of
apoptosis	(Danielson	et	al.,	2002).	Endogenous	oxygen	consumption	 in	mutant	cybrids	was	no	significantly	different	 from	that	 in	wild-type	cybrids	 (Fig.	2C).	Active	caspase-3	 levels	were	significantly	higher	 in	both	cybrids	with	 the
m.3460G > A	mutation	(O3460	and	A3460)	and	significantly	lower	in	O11778.	There	was	no	difference	between	O14484	and	Owt	(Fig.	2D).
All	these	results	suggested	that,	besides	LHON	mutation,	other	factors	were	required	for	phenotype	expression	in	patients.	Below,	we	explore	environmental	exposures.
3.2	Oxygen	consumption
3.2.1	Rotenone
First,	we	analyzed	the	rotenone	effect	on	oxygen	consumption	in	4	osteosarcoma	143B	cybrids.	The	blood	rotenone	concentrations	from	dead	persons	by	insecticide	ingestion	were	between	10.3 nM	and	6.1 μM	(De	Wilde	et	al.,	1986;	Patel,	2011;
Rhee	et	al.,	2016).	Rotenone	is	also	present	in	plants.	Yam	bean	is	a	common	food,	but	its	seeds	are	rarely	consumed	because	contain	rotenone	and	are	poisonous	(Hung	et	al.,	2007).	Blood	from	a	dead	person	by	Yam	bean	seeds	ingestion	showed	a
rotenone	concentration	of	182 nM	(Narongchai	et	al.,	2005).	After	these	reports,	we	selected	rotenone	concentrations	≤6.25 nM.
Compared	with	untreated	cybrids,	 rotenone	0.5 nM	decreased	oxygen	consumption	 in	Owt	and	O3460	cybrids	 (Fig.	3A).	This	concentration	had	apparently	a	 larger	effect	on	O11778	and	O14484	cybrids,	but	a	higher	 rotenone	concentration
(2.5 nM)	was	required	to	significantly	diminish	oxygen	consumption	in	these	cybrids.	Similar	to	other	studies	on	osteosarcoma	143B	cybrids	(Carelli	et	al.,	2002;	Datta	et	al.,	2016),	rotenone	effect	was	dose-dependent.	Thus,	there	were	significant	negative
correlations	between	rotenone	concentrations	and	oxygen	consumption	(Table	2).	We	did	not	observe	significant	differences	to	rotenone	sensitivity	between	mutant	and	wild-type	cybrids	(Fig.	3A).	However,	at	rotenone	2.5 nM	O3460	were	more	resistant
than	O11778	cybrids.	At	rotenone	3.75 nM,	O3460	were	more	resistant	than	O11778	and	O14484	cybrids.
Fig.	3	Rotenone	effect	on	endogenous	oxygen	consumption.	A)	Osteosarcoma	143B	cybrids.	B)	Adenocarcinoma	A549	cybrids.	The	value	for	each	untreated	cybrid	is	considered	100%	(dashed	line).	*	(vs	untreated	cybrid),	P	≤	0.0450.	#	(vs	O3460	or	A3460	at	the	same	rotenone
concentration),	P ≤ 0.0496.
Table	2	Statistical	correlations	between	xenobiotic	concentrations	and	basal	oxygen	consumption.
alt-text:	Table	2
Cybrid Rotenone Capsaicin Rolliniastatin-1
Osteosarcoma	143B
Owt y	=	-	11.0	x	+	92.8 y	=	-	2.0	x	+	115.0 y	=	-	0.12	x	+	114.0
R2 = 0.9215 R2 = 0.9964 R2 = 0.9582
O3460 y	=	-	10.8	x	+	101.7 y	=	-	2.0	x	+	91.9 y	=	-	0.15	x	+	109.3
R2 = 0.9982 R2 = 0.9535 R2 = 0.9582
O11778 y	=	-	11.9	x	+	89.1 y	=	-	1.6	x	+	103.7 y	=	-	0.08	x	+	109.1
R2 = 0.8867 R2 = 0.9983 R2 = 0.9802
O14484 y	=	-	11.2	x	+	92.4 y	=	-	1.9	x	+	105.8 y	=	-	0.09	x	+	107.8
R2 = 0.9404 R2 = 0.9990 R2 = 0.9823
Adenocarcinoma	A549
Awt y	=	-	11.2	x	+	100.2 y	=	-	1.9	x	+	114.1 y	=	-	0.07	x	+	105.6
R2 = 0.9674 R2 = 0.9742 R2 = 0.9876
A3460 y	=	-	13.0	x	+	108.2 y	=	-	2.2	x	+	85.8 y	=	-	0.11	x	+	101.7
R2 = 0.9870 R2 = 0.9282 R2 = 0.9990
A11778 y	=	-	13.3	x	+	95.4 y	=	-	1.5	x	+	101.7 y	=	-	0.11	x	+	113.9
R2 = 0.8861 R2 = 0.9803 R2 = 0.9819
All	correlations	were	statistically	significant	(P < 0.0001).
In	 adenocarcinoma	 A549	 cybrids,	 rotenone	 1.25 nM	 was	 required	 to	 diminish	 oxygen	 consumption	 in	 Awt	 and	 A11778	 cybrids.	 Rotenone	 2.5 nM	 decreased	 oxygen	 consumption	 in	 A3460	 cybrids	 (although,	 0.5 nM	 also	 decreased	 oxygen
consumption	in	this	cybrid)	(Fig.	3B).	There	were	also	significant	negative	correlations	between	rotenone	concentrations	and	oxygen	consumption	(Table	2).	We	did	not	observe	significant	differences	to	rotenone	sensitivity	between	mutant	and	wildtype
cybrids	(Fig.	3B),	but	again,	at	rotenone	2.5	and	3.75 nM,	A3460	were	more	resistant	than	A11778	cybrids.	No	significant	differences	were	found	between	cybrids	with	different	nuclear	and	mitochondrial	genetic	backgrounds	but	with	the	same	LHON
mutation	and	drug	concentration.	These	results	suggested	that	m.3460G > A	mutation	modified	the	rotenone	phenotypic	effect	but	other	nDNA	and	mtDNA	factors	had	less	effect.
3.2.2	Capsaicin
The	genus	Capsicum	(pepper)	includes	a	large	number	of	cultivated	species.	The	plants	are	grown	all	over	the	world.	Pepper	fruits	have	been	used	for	fresh	and	cooked	consumption,	as	well	as	for	medicinal	purposes.	These	fruits	are	enriched	in
CI	inhibitor	capsaicin	(Anonymous,	2007;	Barceloux,	2009;	Wahyuni	et	al.,	2013).	Capsaicin	concentrations	ranged	from	8	to	6639 mg kg−1	in	dried	fruit	(Garces-Claver	et	al.,	2006).	At	least	220 mg	of	capsaicin	have	to	be	consumed	for	reaching	a	plasma
concentration	of	100 μM	(Hochkogler	et	al.,	2018).	Capsaicin	240 μM	decreased	oxygen	consumption	 in	human	promyelocytic	 leukemia	HL60 cells	(Herst	et	al.,	2004).	 In	human	 squamous	cell	 carcinoma	COLO-16	and	SRB-12 cells,	 capsaicin	 100 μM
inhibited	oxygen	consumption	(Hail	and	Lotan,	2002).	It	has	been	reported	that	capsaicin	≥10 μM	caused	a	concentration	dependent	decrease	in	oxygen	consumption	of	isolated	rat	heart	mitochondria	(Athanasiou	et	al.,	2007).	In	human	hepatocellular
carcinoma	HepG2	cells,	≥	0.1 μM	capsaicin	reduced	oxygen	consumption	(Hochkogler	et	al.,	2018).	We	checked	capsaicin	concentrations	below	30 μM	and	found	immediate	reductions	of	oxygen	consumption.	Compared	with	untreated	cybrids,	capsaicin
10 μM	decreases	oxygen	consumption	in	O3460	and	O14484	cybrids	(Fig.	4A).	A	higher	capsaicin	concentration	(20 μM)	is	required	to	diminish	oxygen	consumption	in	O11778	and	Owt	cybrids.	Capsaicin	effect	is	dose-dependent.	Thus,	there	are	significant
negative	correlations	between	capsaicin	concentrations	and	oxygen	consumption	(Table	2).	Between	capsaicin	10–20 μM,	O3460	cybrid	is	more	susceptible	to	capsaicin	than	Owt	(Fig.	4A).	Between	capsaicin	5	and	15 μM,	O3460	cybrid	is	more	susceptible
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to	capsaicin	than	O14484	(Fig.	4A).
In	adenocarcinoma	A549	cybrids,	capsaicin	5 μM	decreases	oxygen	consumption	 in	A3460	and	A11778	cybrids	but	10 μM	 is	 required	 to	diminish	oxygen	consumption	 in	Awt	cybrids	 (Fig.	4B).	There	are	also	 significant	negative	 correlations
between	capsaicin	concentrations	and	oxygen	consumption	(Table	2).	The	same	pattern	of	capsaicin	sensitivity	 is	repeated	 in	these	cybrids.	Between	capsaicin	10–30 μM,	A3460	cybrid	 is	more	susceptible	than	Awt	or	A11778	(Fig.	4B).	No	significant
differences	are	found	between	cybrids	from	different	nuclear	and	mitochondrial	genetic	backgrounds	but	with	the	same	LHON	mutation	and	drug	concentration.	These	results	suggested	that	m.3460G > A	mutation	modified	the	capsaicin	phenotypic	effect
but	other	nDNA	and	mtDNA	factors	had	less	effect.
3.2.3	Rolliniastatin-1
Tropical	 and	 subtropical	 annonaceous	 plants	 produce	 acetogenins.	 The	 quantities	 of	 acetogenins	 in	 annonaceous	 fruits	 are	 such	 that	 a	 cumulative	 dose	 sufficient	 to	 cause	 neurodegeneration	 in	 rats	 can	 be	 attained	 in	 humans	 by	 regular
consumption	within	a	year	(Hollerhage	et	al.,	2009).	In	Guadeloupe	(French	West	Indies)	there	is	an	unusually	high	incidence	of	atypical	parkinsonism,	which	has	been	linked	to	regular	consumption	of	these	plants,	in	particular	soursop	(Lannuzel	et	al.,
2003,	2007,	2008).	 The	 thiophene-3-carboxamide	 analog	 of	 annonaceous	 acetogenins	 JCI-20679	 inhibited	 the	 oxygen	 consumption	 of	 human	non-small	 cell	 lung	 carcinoma	NCI-H23 cells	with	 a	 half	maximal	 inhibitory	 concentration	 (IC50)	 of	 170 nM
(Akatsuka	et	al.,	2016).	The	acetogenin	bullatacin,	or	rolliniastatin-2,	inhibits	respiration	in	insect-derived	Sf9	cells.	The	IC50	was	1.2 nM	(Ahammadsahib	et	al.,	1993).	We	checked	a	more	potent	acetogenin,	rolliniastatin-1,	at	concentrations	below	500	pM
in	osteosarcoma	143B	and	adenocarcinoma	A549	cybrids.
Compared	with	untreated	cybrids,	rolliniastatin-1	≥	200	pM	decreases	oxygen	consumption	in	all	osteosarcoma	cybrids	(Fig.	5A).	Rolliniastatin-1	effect	is	dose-dependent.	Thus,	there	are	significant	negative	correlations	between	rolliniastatin-1
concentrations	and	oxygen	consumption	(Table	2).	At	concentrations	≥200	pM,	O3460	cybrid	 is	more	susceptible	to	rolliniastatin-1	than	the	other	cybrids	(Fig.	5A).	At	concentrations	≥400	pM,	Owt	cybrid	 is	more	susceptible	than	O11778	or	O14484
cybrids	(Fig.	5A).
Fig.	4	Capsaicin	effect	on	endogenous	oxygen	consumption.	A)	Osteosarcoma	143B	cybrids.	B)	Adenocarcinoma	A549	cybrids.	The	value	for	each	untreated	cybrid	is	considered	100%	(dashed	line).	*	(vs	untreated	cybrid),	P	≤	0.0277.	#	(vs	O3460	or	A3460	at	the	same	capsaicin
concentration),	P ≤ 0.0458.
alt-text:	Fig.	4
In	adenocarcinoma	A549	cybrids,	rolliniastatin-1	≥	100	pM	decreases	oxygen	consumption	in	Awt	cybrids	but	≥200	pM	are	required	to	diminish	oxygen	consumption	in	A3460	and	A11778	cybrids	(Fig.	5B).	There	are	also	significant	negative
correlations	between	rolliniastatin-1	concentrations	and	oxygen	consumption	 (Table	2).	The	same	pattern	of	 rolliniastatin-1	sensitivity	 is	 repeated	 in	 these	cybrids.	At	concentrations	≥200	pM,	A3460	cybrid	 is	more	 susceptible	 to	 rolliniastatin-1	 than
A11778	cybrid.	At	concentrations	≥400	pM,	A3460	cybrid	is	more	susceptible	than	Awt	cybrid.	At	100	pM,	Awt	cybrid	is	more	susceptible	than	A11778	cybrid	(Fig.	5B).	A3460	cybrid	is	more	resistant	than	O3460	cybrid	to	rolliniastatin-1400	and	500	pM
concentrations.	Awt	cybrid	is	more	resistant	than	Owt	cybrid	to	rolliniastatin-1500	pM.	However,	 it	 is	more	sensitive	to	rolliniastatin-1	≤	200	pM	(Fig.	5B).	These	results	suggest	that	other	nDNA	or	mtDNA	factors	beside	the	LHON	mutation	are	also
involved	in	the	rolliniastatin-1	susceptibility.
3.3	Apoptosis
The	previous	results	suggested	that	m.3460G > A/p.MT-ND1:A52T	mutation	modifies	CI	interaction	with	these	compounds,	making	these	cybrids	more	resistant	to	rotenone,	but	more	susceptible	to	capsaicin	and	rolliniastatin-1.
To	confirm	these	observations,	we	determined	active	caspase-3	levels	in	Owt	and	O3460	after	exposure	to	rotenone	(2.5	and	5 nM),	capsaicin	(15	and	30 μM)	and	rolliniastatin-1	(200	and	400	pM).	A	reduction	on	ATP	levels	and	an
increase	in	reactive	oxygen	species	(ROS)	production	are	potential	factors	to	trigger	apoptosis.	Similar	rotenone	(1 nM),	capsaicin	(20 μM),	and	rolliniastatin-2	(2500	pM)	concentrations	had	already	shown	to	increase	active	caspase-3
levels	 in	 other	 cell	 lines,	 such	 as	 human	 cervical	 cancer	HeLa,	 osteosarcoma	U2OS	 and	MG63,	 and	 epidermoid	 carcinoma	 KBv200 cell	 lines,	 respectively	 (Agarwal	 et	 al.,	 2016;	Liang	 et	 al.,	 2009;	Ying	 et	 al.,	 2013).	 Both	 rotenone
concentrations	and	 the	 rolliniastatin-1	highest	 one	 significantly	 increased	active	 caspase-3	 levels	 in	Owt	 (Fig.	6).	Both	 capsaicin	and	 rolliniastatin-1	 concentrations	 significantly	 increased	active	 caspase-3	 levels	 in	O3460	cybrids.
Interestingly,	highest	toxic	concentrations	(and	the	lowest	rotenone	concentration)	differentially	affected	Owt	and	O3460.	Similar	to	oxygen	consumption	results,	Owt	cybrids	were	more	susceptible	to	rotenone	than	O3460	cybrids	and
O3460	cybrids	were	more	susceptible	to	capsaicin	and	rolliniastatin-1	than	Owt	cybrids.	To	analyze	a	different	nuclear	genetic	background,	we	also	checked	the	rolliniastatin-1	effect	on	Awt	and	A3460	active	caspase-3	levels.	Both
toxic	concentrations	increased	these	levels	in	A3460	cybrid	and	there	was	a	difference	between	A3460	and	Awt	for	the	highest	concentration	(Fig.	6).	The	active	caspase-3	level	was	higher	in	osteosarcoma	cybrids	exposed	to	400	pM
rolliniastatin-1	than	in	adecarcinoma	ones.	Therefore,	they	were	more	susceptible	to	this	drug,	confirming	the	result	obtained	for	endogenous	oxygen	consumption.
Fig.	5	Rolliniastatin-1	effect	on	endogenous	oxygen	consumption.	A)	Osteosarcoma	143B	cybrids.	B)	Adenocarcinoma	A549	cybrids.	The	value	for	each	untreated	cybrid	is	considered	100%	(dashed	line).	*	(vs	untreated	cybrid),	P	≤	0.0464.	#	(vs	O3460	or	A3460	at	the	same
rolliniastatin-1	concentration),	P ≤ 0.0448.	&	(vs	Owt	or	Awt	at	the	same	rolliniastatin-1	concentration),	P ≤ 0.0448.	$	(vs	Owt	or	O3460	at	the	same	rolliniastatin-1	concentration),	P ≤ 0.0348.
alt-text:	Fig.	5
4	Discussion
The	 endogenous	 oxygen	 consumption	 in	O3460,	O11778	 or	O14484	 cybrids	was	 not	 different	 from	Owt	 cybrids.	Besides	 culture	 conditions	 and	nDNA	genetic	 background,	 all	 these	 cybrids	 also	 shared	 the	 same	mtDNA
haplogroup	J.	However	this	fact	did	not	happen	for	A3460,	A11778	and	Awt.	Despite	they	belong	to	different	mtDNA	haplogroups,	they	did	not	show	differences	in	endogenous	oxygen	consumption.	It	was	previously	reported	that	the
rates	of	glutamate-malate-,	pyruvate-malate-	or	succinate-driven	respiration	were	not	 lower	 in	osteosarcoma	143B	cybrids	with	LHON	mutations	(Baracca	et	al.,	2005;	Porcelli	et	al.,	2009).	Moreover,	although	endogenous	oxygen
consumption	was	significantly	decreased	in	some	osteosarcoma	143B	cybrids	carrying	LHON	mutations	(Cruz-Bermudez	et	al.,	2016;	Floreani	et	al.,	2005;	Jiang	et	al.,	2016b;	Vergani	et	al.,	1995),	it	was	not	found	different	in	others
(Cruz-Bermudez	et	al.,	2016;	Floreani	et	al.,	2005;	Hofhaus	et	al.,	1996;	Martinez-Romero	et	al.,	2014).	Similar	variability	was	also	previously	reported	for	active	caspase	3	levels.	The	Owt	active	caspase-3	amount	was	similar	to	that	of
O14484,	but	was	higher	and	lower	than	that	of	O11778	and	O3460	(and	A3460),	respectively.	No	cleavage	of	caspase	3	was	found	in	wild-type	or	mutant	(m.3460G > A,	m.11778G > A	or	m.14484T > C)	osteosarcoma	143B	cybrids	in
another	study	(Zanna	et	al.,	2003).	Moreover,	no	differences	in	active	caspase-3	levels	were	found	between	wild-type	and	m.11778G > A	osteosarcoma	143B	cybrids	(Danielson	et	al.,	2002).
Despite	LHON	individuals	are	usually	homoplasmic	mutants,	only	retinal	ganglion	cells,	highly	dependent	on	OXPHOS	energy,	are	affected.	The	analysis	of	other	unaffected	cells	in	LHON	individuals,	such	as	blood	cells	or
fibroblasts	that	are	less	dependent	on	mitochondrial	energy,	might	be	the	reason	why	most	of	patients	do	not	show	respiratory	chain	defects.	The	reason	for	the	absence	of	differences	between	LHON	mutant	and	wild-type	cybrids
could	be	their	generation	from	very	glycolytic	tumor	cell	lines	and	their	lower	dependence	on	OXPHOS	energy	in	basal	situations.	However,	stress	conditions,	increasing	OXPHOS	energy	requirements,	might	push	cells	to	a	limit.	In	this
sense,	the	optic	nerve	preceding	the	lamina	cribrosa	is	characterized	by	an	altered	blood-brain	barrier	with	non-specific	vesicular	permeability	(Hofman	et	al.,	2001).	Maybe	this	feature	makes	optic	nerve	more	susceptible	to	toxic
damage	from	environmental	chemicals.	We	have	shown	that	low	concentrations	of	natural	CI	inhibitors,	present	in	fruits	frequently	used	in	human	feeding,	alter	mitochondrial	bioenergetics	parameters,	such	as	oxygen	consumption,
and	apoptotic	variables,	such	as	active	caspase-3	levels.	As	an	OXPHOS	dysfunction	appears	to	be	the	etiologic	factor	for	LHON,	the	exposure	to	these	compounds	would	facilitate	developing	LHON.	Of	course,	the	involvement	of	these
fruits	as	LHON	triggers	would	require	more	investigation	(see	https://scienceofparkinsons.com/2017/12/16/paq/#more-48745).
The	differential	susceptibility	to	these	compounds	would	help	to	explain	the	incomplete	penetrance	of	LHON	mutations.	We	have	shown	that	A3460	and	O3460	cybrids	resist	better	rotenone	toxic	effects.	The	amino	acid	at	p.
MT-ND1	position	52	is	part	of	the	amphipathic	helix	1	(AH1)	that,	along	with	p.	MT-ND3,	frames	the	entrance	into	the	coenzyme	Q	binding	(Q)-site	(Baradaran	et	al.,	2013;	Hirst,	2013;	Martinez-Romero	et	al.,	2014),	and	rotenone	is	a
Q-site	inhibitor	(Hirst	and	Roessler,	2016).	This	threonine	might	difficult	rotenone	access	to	CI	Q-site.	Interestingly,	it	has	been	recently	showed	that	oxygen	consumption	of	osteosarcoma	143B	cybrids	from	mtDNA	haplogroups	J1	and
K1	is	more	sensitive	to	rotenone	10 nM	than	that	of	cybrids	from	haplogroup	H1	(Strobbe	et	al.,	2018).	These	J1	and	K1	cybrids	share	a	m.10398A > G	mutation,	which	cause	a	p.	MT-ND3:T114A	amino	acid	substitution.	The	J1	cybrid
also	harbors	a	m.4216T > C	mutation,	which	cause	a	p.	MT-ND1:Y304H	amino	acid	change.	This	position	is	also	close	to	p.	MT-ND1	residues	implicated	in	the	Q-site	(Strobbe	et	al.,	2018).	All	our	osteosarcoma	143B	cybrids	are	from
mtDNA	haplogroup	J	and	harbor	the	p.	MT-ND1:304H	amino	acid	and,	similarly	to	the	Strobbe's	rotenone	susceptible	J1	and	K1	cybrids,	our	more	rotenone	vulnerable	cybrids	(O11778	and	O14484)	are	also	p.	MT-ND3:114A.	This
alanine	might	 facilitate	 rotenone	 access	 to	CI	Q-site.	However,	 it	 has	 been	 reported	 that	 cleaved	 caspase-3	 levels	 are	 lower	 in	 100 nM	 rotenone-treated	 osteosarcoma	 143B	 cybrids	 from	mtDNA	 haplogroup	 B5	 than	 those	 from
haplogroup	B4.	They	are,	apparently,	more	resistant	to	this	high	toxic	concentration,	but	B5	cybrids	harbor	a	p.	MT-ND3:114A	amino	acid	(Liou	et	al.,	2016).	Thus,	considering	that	the	same	osteosarcoma	143B	nDNA	background	has
been	used	in	these	three	publications,	other	factors	must	be	also	involved	in	rotenone	susceptibility.
Fig.	6	Effect	of	CI	inhibitors	on	active	caspase-3	levels.	The	value	for	each	untreated	cybrid	is	considered	100%	(dashed	line).	*	(vs	untreated	cybrid),	P	≤	0.0394.	#	(vs	O3460	or	A3460	at	the	same	drug	concentration),	P ≤ 0.0241.	$	(vs	Owt	or	O3460	at	the	same	rolliniastatin-1
concentration),	P ≤ 0.0006.
alt-text:	Fig.	6
We	 have	 also	 observed	 that	 m.3460G > A	 cybrids	 are	 more	 susceptible	 to	 capsaicin	 and	 rolliniastatin-1.	 The	 bis-tetrahydrofuran	 motif	 of	 rolliniastatin-1	 bind	 the	 third	 matrix-side	 loop	 connecting	 the	 fifth	 and	 sixth
transmembrane	helices	in	the	p.	MT-ND1	subunit	(Kakutani	et	al.,	2010;	Murai	et	al.,	2007,	2009;	Nakanishi	et	al.,	2011;	Sekiguchi	et	al.,	2009).	This	third	matrix	loop	is	at	the	same	side	of	p.	MT-ND1	position	52,	in	which	alanine	has
changed	by	threonine	in	m.3460G > A	mutants	(Fig.	7).	Maybe	this	new	amino	acid	favors	a	tighter	interaction	with	acetogenins	and	other	compounds,	such	as	capsaicin.	The	interface	between	the	49 kDa	and	p.	MT-ND1	subunits
forms	the	inhibitor/Q-site,	although	it	is	considered	that	different	CI	inhibitors	act	on	the	same	Q-site	with	different	but	partially	overlapping	sites	(Okun	et	al.,	1999;	Sinha	et	al.,	2015).
On	the	other	hand,	m.11778G > A	and	m.14484T > C	mutations	cause	p.	MT-ND4:R340H	and	p.	MT-ND6:M63V	amino	acid	substitutions,	respectively.	These	polypeptides	are	not	part	of	the	Q-site,	and	this	would	explain	why
toxic	effects	of	these	compounds	are	very	similar	in	Owt,	O11778	and	O14484,	and	also	in	Awt	and	A11778,	cybrids.	Some	small	differences	must	be	due	to	other	population	polymorphisms	in	p.	MT-ND1	and	3	(Table	1C).	Similar
polymorphisms	could	explain	why	m.11778G > A	osteosarcoma	143B	cybrids	were	more	sensitive	to	rotenone	(IC50	4.7 nM)	compared	to	wild-type	cybrids	(Datta	et	al.,	2016).	In	this	sense,	it	was	also	found	that	a	man	harboring	the
m.11778G > A	mutation	developed	LHON	after	his	exposure	to	n-hexane.	He	had	increased	concentrations	of	urinary	2,5-hexanedione	(2,5-HD),	an	n-hexane	metabolite,	in	the	period	immediately	preceding	the	visual	loss	(Carelli	et	al.,
2007).	Sensitivity	to	2,5-HD	induced	cell	death	was	greatly	increased	in	osteosarcoma	143B	cybrids	carrying	the	m.11778G > A	or	the	m.14484T > C	mutations	on	haplogroup	J,	whereas	the	m.11778G > A	mutation	in	association	with
haplogroups	U	and	H	significantly	improved	cell	survival.	Thus,	mtDNA	genetic	background	can	modify	the	interaction	with	environmental	factors	(Ghelli	et	al.,	2009).
Capsaicin	is	found	in	food.	Foods	can	be	a	frequent	source	of	compounds	that	differentially	act	as	risk	factors	for	LHON	depending	on	the	mtDNA	genetic	background.	However,	capsaicin	is	also	a	pharmacologic	drug	currently
used	to	treat	various	diseases	(Ying	et	al.,	2013).	Other	pharmacologic	compounds	show	similar	behavior.	For	example,	benzalkonium	chloride	is	the	most	commonly	used	eye	drop	preservative,	but	it	has	been	associated	with	toxic
effects.	Pharmacologically	relevant	concentrations	of	this	compound	inhibit	CI	activity	and	reduce	oxygen	consumption	in	osteosarcoma143B	cybrids	(Datta	et	al.,	2017).	Moreover,	the	m.11778G > A	mutation	conferred	significantly
increased	sensitivity	to	benzalkonium	chloride	(Datta	et	al.,	2017).
We	have	previously	suggested	that	mtDNA	genetic	background	 in	 the	cytochrome	b	gene	might	affect	 the	 interaction	with	pesticides	or	pharmaceutical	drugs	 (Gomez-Duran	et	al.,	2011).	Moreover,	we	 found	 that	mtDNA
genetic	variation	modifies	the	off-target	effects	of	ribosomal	antibiotics	used	to	fight	pathogenic	bacteria	(Pacheu-Grau	et	al.,	2013),	and	that	the	widely	distributed	pollutant	tributyltin	chloride,	an	ATP	synthase	inhibitor,	modified	the
phenotypic	 effects	 caused	 by	 a	 pathological	 mtDNA	mutation	 (Lopez-Gallardo	 et	 al.,	 2016).	 Thus,	 considering	 the	 interaction	 between	 mtDNA	 and	 environment	 factors	 is	 going	 to	 be	 important	 to	 explain	 the	 pathogenicity	 of
mitochondrial	disease	due	to	mtDNA	mutations.
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Fig.	7	Molecular	model	of	the	bovine	p.	MT-ND1	subunit,	ortholog	of	human	p.	MT-ND1	subunit.	The	third	matrix-side	loop,	which	binds	rolliniastatin-1	bis-tetrahydrofuran	motif,	is	shown	in	red	color.	The	alanine	at	position	52,	which	is	mutated	to	threonine
in	m.3460G > A,	is	represented	in	green	color.	(For	interpretation	of	the	references	to	color	in	this	figure	legend,	the	reader	is	referred	to	the	Web	version	of	this	article.)
alt-text:	Fig.	7
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